COVID-19 Vaccination Information

Provider Information

Vaccine Locations

The Louisiana Department of Health is coordinating the COVID-19 vaccine distribution effort in Louisiana. As more vaccines become available from the CDC, more individuals and groups will be offered a vaccination.

Limited amounts of COVID vaccines will be available beginning January 4, 2021 at some local locations.

These vaccines will be available only for:

  • Persons ages 70 years or older in the community,
  • Outpatient clinic providers and clinic staff,
  • Urgent care clinic providers and staff,
  • Community care clinic providers and staff,
  • Behavioral health providers and staff,
  • Dialysis providers and patients,
  • Home health service providers and recipients,
  • Dental providers and staff, and
  • Students, residents, faculty and staff of allied health schools (if not already receiving vaccine or in a plan to receive from their respective schools)
  • Click HERE for Vaccine Locations.

    Patients must contact a participating location and make an appointment at the location. Do not arrive at a location without an appointment. LDH cannot make appointments for residents; only participating locations can.

    Vaccine Communication Materials 

    Reporting Adverse Reactions

    After a vaccine is authorized or approved for use, many vaccine safety monitoring systems watch for adverse events (possible side effects). This continued monitoring can pick up on adverse events that may not have been seen in clinical trials. If an unexpected adverse event is seen, experts quickly study it further to assess whether it is a true safety concern. Experts then decide whether changes are needed in U.S. vaccine recommendations. This monitoring is critical to help ensure that the benefits continue to outweigh the risks for people who receive vaccines.

    Immediately (24/7) report severe COVID-19 vaccine reactions requiring hospitalization to the Office of Public Health (OPH) at 1-800-256-2748. For more information, view the Health Alert Networks Message 20-52: COVID-19 Vaccination Severe/Allergic Reaction Reporting.

    v-safe

    v-safe is a smartphone-based tool that uses text messaging and web surveys to provide personalized health check-ins after you receive a COVID-19 vaccination. Through v-safe, you can quickly tell CDC if you have any side effects after getting the COVID-19 vaccine. Depending on your answers, someone from CDC may call to check on you and get more information. V-safe will also remind you to get your second COVID-19 vaccine dose if needed. For more information, click here.

    Vaccine Adverse Emergency Reporting System (VAERS)

    VAERS is a national early warning system to detect possible safety problems in U.S.-licensed vaccines. VAERS is co-managed by the Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration (FDA). VAERS accepts and analyzes reports of adverse events (possible side effects) after a person has received a vaccination. Anyone can report an adverse event to VAERS. Healthcare professionals are required to report certain adverse events and vaccine manufacturers are required to report all adverse events that come to their attention.

    Report an Adverse Event

    More Information on VAERS

    Achieving Herd Immunity Through Vaccinations

    To access more information on COVID-19 vaccines and Herd Immunity, click here.

    Federal Pharmacy Partnership for LTC Program in Louisiana

    All licensed LTCs in Louisiana are set to receive on-site COVID-19 vaccinations through either Walgreens or CVS. Click here for more information.

    Additional information

    To view a U.S. Health and Human Services video called "Tell Me More About Vaccines" click here.

    Below are other key updates on the COVID-19 vaccine:

    • The Louisiana Department of Health’s (LDH) Office of Public Health will follow the CDC's Advisory Committee for Immunization Practices (ACIP) to guide recommendations on which populations should be vaccinated with any of the COVID-19 vaccines that come on to the market after FDA approval.
    • A multi-platform communications and marketing plan is  being developed that includes steps for conducting outreach to groups most affected by COVID-19 and continues efforts to ensure reaching the most vulnerable groups and underserved areas.
    • Public health officials will be reaching out proactively to vaccination sites to ensure that the infrastructure and systems are in place for populations to receive vaccinations as soon as they become available in Louisiana. 

     Wear a Mask